Novel Pharmacological Treatment Attenuates Septic Shock and Improves Long-Term Survival

[1]  Andrew Rhodes,et al.  Drotrecogin alfa (activated) in adults with septic shock. , 2012, The New England journal of medicine.

[2]  R. Wenzel,et al.  Septic shock--evaluating another failed treatment. , 2012, The New England journal of medicine.

[3]  Sun-Mee Lee,et al.  Genipin Attenuates Sepsis by Inhibiting Toll-Like Receptor Signaling , 2012, Molecular medicine.

[4]  T. Libermann,et al.  Creating a "pro-survival" phenotype through epigenetic modulation. , 2012, Surgery.

[5]  D. King,et al.  Anti-inflammatory properties of histone deacetylase inhibitors: A mechanistic study , 2012, The journal of trauma and acute care surgery.

[6]  C. Blobel,et al.  iRhom2 Regulation of TACE Controls TNF-Mediated Protection Against Listeria and Responses to LPS , 2012, Science.

[7]  Dakang Xu,et al.  HDACi: molecular mechanisms and therapeutic implications in the innate immune system , 2012, Immunology and cell biology.

[8]  R. Hotchkiss,et al.  Immunosuppression in patients who die of sepsis and multiple organ failure. , 2011, JAMA.

[9]  M. Sweet,et al.  Histone deacetylases as regulators of inflammation and immunity. , 2011, Trends in immunology.

[10]  G. Velmahos,et al.  Treatment with histone deacetylase inhibitor attenuates MAP kinase mediated liver injury in a lethal model of septic shock. , 2010, The Journal of surgical research.

[11]  G. Velmahos,et al.  Surviving lethal septic shock without fluid resuscitation in a rodent model. , 2010, Surgery.

[12]  G. Velmahos,et al.  PROTECTIVE EFFECT OF SUBEROYLANILIDE HYDROXAMIC ACID AGAINST LPS-INDUCED SEPTIC SHOCK IN RODENTS , 2009, Shock.

[13]  E. Abraham,et al.  miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses , 2009, Proceedings of the National Academy of Sciences.

[14]  Y. Fujii‐Kuriyama,et al.  Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses , 2009, The Journal of experimental medicine.

[15]  J. Bradner,et al.  Tubacin Kills Epstein-Barr Virus (EBV)-Burkitt Lymphoma Cells by Inducing Reactive Oxygen Species and EBV Lymphoblastoid Cells by Inducing Apoptosis* , 2009, The Journal of Biological Chemistry.

[16]  B. Porse,et al.  Bone Marrow-Derived Macrophages (BMM): Isolation and Applications. , 2008, CSH protocols.

[17]  Peter A. Ward,et al.  Harmful molecular mechanisms in sepsis , 2008, Nature Reviews Immunology.

[18]  P. Marks,et al.  Histone deacetylase inhibitors: molecular mechanisms of action , 2007, Oncogene.

[19]  Shizuo Akira,et al.  TLR signaling pathways. , 2004, Seminars in immunology.

[20]  B. Beutler,et al.  Identification of a TLR4‐ and TRIF‐dependent activation program of dendritic cells , 2004, European journal of immunology.

[21]  G. Fantuzzi,et al.  The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Rittirsch,et al.  Immunodesign of experimental sepsis by cecal ligation and puncture , 2008, Nature Protocols.

[23]  Chunlei Zhang,et al.  Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). , 2007, Blood.

[24]  R. Stauber,et al.  Acetylation of Stat1 modulates NF-kappaB activity. , 2006, Genes & development.